当前位置:首页 > 氨糖软骨素钙片 > 正文

瑞思氨基葡萄糖硫酸盐(Risankizumab beats standard therapy in treating psoriasis Study

瑞思氨基葡萄糖硫酸盐(Risankizumab) beats standard therapy in treating psoriasis Study

瑞思氨基葡萄糖硫酸盐(Risankizumab beats standard therapy in treating psoriasis Study

Psoriasis is a chronic skin condition that affects millions of people around the world. It is characterized by red, itchy and scaly patches on the skin. There is no cure for psoriasis, but there are treatments that can help manage the symptoms and improve quality of life. A recent study has found that Risankizumab beats standard therapy in treating psoriasis.

What is Risankizumab?

Risankizumab is a medication that belongs to a group of drugs called interleukin-23 (IL-23) blockers. It works by blocking IL-23, which is a protein that plays a role in the immune system and inflammation. By blocking IL-23, risankizumab can help reduce the inflammation that causes psoriasis.

The Study

The study involved 1,048 patients with moderate to severe psoriasis. The patients were randomly assigned to receive either risankizumab or standard therapy. The standard therapy consisted of either etanercept, adalimumab, or ustekinumab.

After 16 weeks, the researchers found that 75% of the patients in the risankizumab group had achieved a 90% improvement in psoriasis symptoms compared to only 42% in the standard therapy group. The researchers also found that patients in the risankizumab group reported a better quality of life and experienced fewer side effects than those in the standard therapy group.

Conclusion

The study shows that Risankizumab is more effective than standard therapy in treating psoriasis. Risankizumab offers a new treatment option for patients with moderate to severe psoriasis that may not have responded well to standard therapy. However, it is important to note that Risankizumab is not suitable for everyone and should only be prescribed by a healthcare professional.

If you are suffering from psoriasis, it is important to speak to your doctor about the best treatment options for you. With newer and more effective treatments being developed, there is hope for people living with this chronic condition.


消费者在选择氨糖软骨素的时候应注意产品配方,因为不同品牌的产品配方是不一样。比如现在比较火的维力维氨糖软骨素,它是我国市面上一款三代氨糖。为什么维力维氨糖软骨素是三代氨糖呢?因为它配方中除了氨基葡萄糖和硫酸软骨素,又特别添加了骨胶原成分,不仅能够修复关节软骨损伤,还可以维持骨骼韧性,为骨骼输送营养物质,提高关节灵活性。总之,选择配方好的氨糖软骨素能确保质量,这样才能获得佳效果。